LGND
Ligand Pharmaceuticals Incorporated
298.40$
+0.0%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +106.9% | +12.7% | +11.5% | +87.9% | +18.6% | -8.9% | -4.7% | -41.2% | +3.2% | +19.6% | +65.7% | |
| – | +16.4% | -24.4% | +45.4% | +267.3% | +29.1% | -55.5% | -7.2% | -43.3% | -9.9% | +39.6% | +151.0% | |
| – | +19.7% | -29.6% | +43.0% | +256.2% | -90.0% | -33.4% | -59.0% | +130.5% | -49.0% | +215.0% | +141.9% | |
| – | +19.7% | -29.6% | +43.0% | +279.1% | +39.9% | -61.6% | -17.0% | -37.9% | -19.6% | +50.4% | +186.3% | |
| – | -14.4% | +53.3% | +64.6% | +89.5% | -25.2% | +41.5% | +55.2% | -61.8% | +12.2% | +8.0% | +43.8% | |
| – | +507.1% | +17.8% | +127.4% | +62.9% | +2.4% | +263.0% | +3.2% | -51.4% | +80.3% | -41.1% | -35.3% | |
| – | -57.1% | +389.0% | +131.6% | +27.5% | +33.7% | +100.9% | +126.9% | -16.1% | – | – | – | |
| – | -3.8% | +357.1% | +13.6% | -2.6% | -68.9% | +99.2% | -44.3% | +0.0% | -2.2% | +1.8% | -3.5% | |
| – | +87.3% | +201.9% | -24.4% | +61.1% | +632.8% | +163.0% | -36.2% | -8.8% | -15.0% | -11.0% | +58.4% | |
| – | -1.7% | +0.5% | +9.4% | +177.3% | +4.0% | -10.3% | -27.0% | -65.3% | -47.8% | +29.0% | +388.1% | |
| – | -8.5% | +990.1% | +5.2% | -65.6% | -79.3% | +488.8% | -58.4% | +137.2% | -83.0% | +121.1% | +0.9% | |
| – | +60,374.6% | +5.4% | +5.5% | -88.2% | -95.3% | +575.5% | -83.3% | +5,378.4% | -99.5% | +214.6% | -15.1% | |
| – | -47.0% | +123.6% | +5.5% | -56.6% | -42.1% | +56.4% | +122.1% | -36.8% | -54.3% | +115.6% | -38.1% | |
| – | +1,190.4% | -25.4% | -36.2% | +3,133.8% | +4.8% | -30.8% | -27.5% | – | – | – | – | |
| – | +1,056.6% | +21.8% | +12.9% | +34.0% | +36.8% | -7.5% | +15.7% | -27.2% | +17.3% | +18.5% | +22.5% | |
| – | – | – | – | – | – | -2.0% | +14.6% | +0.4% | +11.6% | -0.8% | +21.9% | |
| – | -1.0% | -1.9% | +12.7% | +2.5% | -17.9% | -18.1% | +6.6% | -2.2% | +5.3% | +3.0% | +11.0% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.